EUVIMEDEUVIMED entdecken
Crossref

UPLC-Q-TOF/MS-based urine metabolomics for the diagnosis and staging of bladder cancer

Xingyu Shi, Wenbin Zheng, Binhong He, Longhui Huang, Qisheng Zhong, Yunfan Yang, Ting Zhou, Yong Huang

Clinica Chimica Acta · 2025

DOI: 10.1016/j.cca.2024.120022 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinica Chimica Acta, 2025. Verfasst von Xingyu Shi und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Biology and Biological Engineering, South China University of Technology, Guangzhou 510006, China. Hauptthemen laut MEDLINE: Urinary Bladder Neoplasms, Metabolomics, Biomarkers, Tumor, Mass Spectrometry. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 45 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Bladder cancer (BC) is a common malignant tumour of the urinary system. Currently, the gold standard for diagnosing BC is cystoscopy, but it is an invasive examination that can lead to a certain psychological burden on the patient. In this study, we aimed to identify non-invasive potential metabolic biomarkers that could improve the diagnostic accuracy of bladder cancer. METHODS: Urine from 30 healthy people and 50 BC patients, including 40 non-muscle-invasive bladder cancer (NMIBC) patients and 10 muscle-invasive bladder cancer (MIBC) patients, were analyzed by liquid chromatography coupled with mass spectrometry to identify potential diagnostic metabolites. Binary Logistic regression was used to construct biomarker panels. Correlation analysis and construction of compound-reaction-enzyme-gene network were also performed to explore the possible mechanisms of BC development. RESULTS: Twenty-six metabolites were identified for differentiating BC patients from healthy controls, and eight metabolites were identified for differentiating NMIBC patients form MIBC patients. The biomarker panel consisting of urate, 4-Androstene-3α, 17β-diol and 3-Indoxyl sulfate can distinguish well between BC patients and healthy controls, with an area under the ROC curve (AUC) value of 0.983. And the biomarker panel consisting of L-Octanoylcarnitine, γ-Glutamylleucine, and heptanoylcarnitine for distinguishing NMIBC patients from MIBC patients had an AUC value of 0.941. CONCLUSIONS: The diagnostic capability of the biomarker panels are superior to that of any single potential biomarker. This panel significantly benefits bladder cancer diagnostics and reveals insight into bladder cancer pathogenesis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Urinary Bladder NeoplasmsMetabolomicsBiomarkers, TumorMass SpectrometryHumansMaleFemaleMiddle AgedChromatography, High Pressure LiquidNeoplasm StagingAged

Stichwörter der Autor:innen

Binary logistic regressionBiomarker panelBladder cancerNon-targeted metabolomics

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • School of Biology and Biological Engineering, South China University of Technology, Guangzhou 510006, China.
  • Department of Emergency, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510080, China.
  • Guangzhou Analytical Applications Center, Shimadzu (China) Co., LTD, Guangdong 510010, China.
  • School of Biology and Biological Engineering, South China University of Technology, Guangzhou 510006, China. Electronic address: tingzhou@scut.edu.cn.
  • Department of Urology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510080, China; Guangxi Hospital Division of The First Affiliated Hospital, Sun Yat-sen University, Nanning 530000, China; Departmen…

Zitieren

APA

Shi, X., Zheng, W., He, B., Huang, L., Zhong, Q., Yang, Y., Zhou, T., & Huang, Y. (2025). UPLC-Q-TOF/MS-based urine metabolomics for the diagnosis and staging of bladder cancer. Clinica Chimica Acta. https://doi.org/10.1016/j.cca.2024.120022

Vancouver

Shi X, Zheng W, He B, Huang L, Zhong Q, Yang Y, et al. UPLC-Q-TOF/MS-based urine metabolomics for the diagnosis and staging of bladder cancer. Clinica Chimica Acta. 2025. doi:10.1016/j.cca.2024.120022

BibTeX
@article{Shi2025,
  author = {Shi, Xingyu and Zheng, Wenbin and He, Binhong and Huang, Longhui and Zhong, Qisheng and Yang, Yunfan and Zhou, Ting and Huang, Yong},
  title = {UPLC-Q-TOF/MS-based urine metabolomics for the diagnosis and staging of bladder cancer},
  journal = {Clinica Chimica Acta},
  year = {2025},
  doi = {10.1016/j.cca.2024.120022}
}
Kostenlos starten →